Back to search
IgAVN
Clinical trial pipeline · Data from ClinicalTrials.gov
See which IgAVN trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which IgAVN trials you may qualify forThe primary objectives of this study are to characterize ravulizumab pharmacokinetics (PK) and pharmacodynamics (PD), and to evaluate safety and efficacy follow…
The purpose of this study is to evaluate the safety and tolerability of atacicept in adult and adolescent participants and to measure the effect in reducing pro…
To further evaluate the efficacy and safety of Telitacicept in the treatment of pediatric IgA vasculitis nephritis (IgAVN) within real-world settings, this stud…
This clinical trial is a prospective, multicenter, non-randomized controlled study designed to evaluate the efficacy and safety of Telitacicept, a novel biologi…